Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FEQW6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,571
Award facts
- Contract value 100% obligated
- $30,571.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,571.22 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg, with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026.
Ondansetron is a widely used antiemetic medication within military and federal healthcare systems, commonly administered to manage nausea and vomiting in various medical contexts. AmerisourceBergen's pharmaceutical supply portfolio with the Defense Logistics Agency encompasses a broad range of medications and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established federal contracting history demonstrates consistent capability in delivering pharmaceutical products through competitive procurement processes with firm fixed pricing structures, making this delivery order a routine fulfillment of medical supply needs within the broader DLA pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DB25FEQW6?
SPE2DB25FEQW6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FEQW6 worth?
The government has obligated $30,571 on SPE2DB25FEQW6.
Is contract SPE2DB25FEQW6 an order under another contract?
Yes. SPE2DB25FEQW6 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEQW6 competed?
The extent of competition for SPE2DB25FEQW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award